Techno Trends
Ireland’s Shire to acquire NPS Pharmaceuticals for $5.2bn
Irish drugmaker Shire has signed a merger agreement to acquire US-based NPS Pharmaceuticals for $5.2bn. As part of the deal, Shire will...
Techno Trends
Biogen to acquire British biopharmaceutical firm Convergence
US-based Biogen Idec is set to acquire British clinical-stage biopharmaceutical company, Convergence Pharmaceuticals. As part of the deal, Convergence shareholders will receive...
Techno Trends
Insourcing IV Sterile Compounding
Determined to cement access to reliable and safe sources for crucial IV drug admixtures, a growing number of hospitals are bringing production of compounded sterile...
Techno Trends
Novartis buys GSK’s cancer drugs for $16 bn in three-part deal
Global pharma major Novartis will acquire GlaxoSmithKline Plc's (GSK) cancer drugs portfolio for $16 billion and sell its vaccines business in return for $7.1 billion,...
Techno Trends
Biocon Q4 net profit falls 54% to Rs 113 crore
Biotechnology firm Biocon on Friday reported a 54.51 per cent fall in its consolidated net profit at Rs 113.08 crore for the fourth quarter ended...
Techno Trends
Lupin forms JV with Japan’s Yoshindo Inc
Drug major Lupin has entered into a joint venture pact with Toyama-based Yoshindo Inc to form a new entity which will be responsible for development...
Techno Trends
Xenometrix – Mutagenicity Assays and Cytotoxicity Screening Kits
Xenometrix produces and distributes today's most advanced mutagenicity assays and cytotoxicity screening kits designed to help reduce hands-on time, test compound consumption, plastic waste and...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.